Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Hoessel R; Leclerc S; Endicott JA; Nobel ME; Lawrie A; Tunnah P; Leost M; Damiens E; Marie D; Marko D; Niederberger E; Tang W; Eisenbrand G; Meijer L; Nature Cell Biology, 1999, vol. 1, issue 1, p 60, ISSN 14657392. ISBN 14657392.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef